These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36530036)

  • 21. Insufficient reporting on race and ethnicity in randomized trials for patients with rheumatoid arthritis: comment on the article by Simsek et al.
    Potter J; Spruill T; Greenberg JD
    Arthritis Care Res (Hoboken); 2013 Apr; 65(4):666. PubMed ID: 23212944
    [No Abstract]   [Full Text] [Related]  

  • 22. Rheumatoid arthritis subgroup with type I interferon signature: comment on the article by Thurlings et al.
    Park JK
    Arthritis Rheum; 2011 Dec; 63(12):4033; author reply 4033-4. PubMed ID: 21882169
    [No Abstract]   [Full Text] [Related]  

  • 23. Level of the indication of biologic agents in the 2012 American College of Rheumatology recommendations for the treatment of rheumatoid arthritis: comment on the article by Singh et al.
    Graudal N; Jürgens G
    Arthritis Care Res (Hoboken); 2013 May; 65(5):832. PubMed ID: 23097263
    [No Abstract]   [Full Text] [Related]  

  • 24. Comment on: Multicentre survey of rheumatoid arthritis patients from Ministry of Health rheumatology centres in Malaysia.
    Yeap SS
    Int J Rheum Dis; 2009 Jul; 12(2):177-8; author reply 179. PubMed ID: 20374340
    [No Abstract]   [Full Text] [Related]  

  • 25. Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: comment on the article by Smolen et al.
    Pincus T; Yazici Y; Yazici H; Kavanaugh AF; Kremer JM; Wolfe F
    Arthritis Rheum; 2005 Dec; 52(12):4044-5; author reply 4045-7. PubMed ID: 16320353
    [No Abstract]   [Full Text] [Related]  

  • 26. Rheumatoid arthritis: past, present and future approaches to treating the disease.
    Hyndman IJ
    Int J Rheum Dis; 2017 Apr; 20(4):417-419. PubMed ID: 26845360
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical contrasts with the American College of Rheumatology/European League Against Rheumatism provisional definitions of remission in rheumatoid arthritis for clinical trials: Comment on the article by Felson et al.
    Rotar Z; Praprotnik S; Tomšič M
    Arthritis Rheum; 2011 Nov; 63(11):3642-3; author's reply 3644. PubMed ID: 21792830
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of folic acid supplementation on the efficacy of methotrexate treatment in rheumatoid arthritis: comment on the article by Khanna et al.
    Morgan SL; Baggott JE; Alarcón GS
    Arthritis Rheum; 2006 May; 54(5):1708-9; author reply 1709-10. PubMed ID: 16646062
    [No Abstract]   [Full Text] [Related]  

  • 29. Response to 'Correspondence on 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study'' by Zheng
    Pappas DA; St John G; Etzel CJ; Fiore S; Blachley T; Kimura T; Punekar R; Emeanuru K; Choi J; Boklage S; Kremer JM
    Ann Rheum Dis; 2022 Nov; 81(11):e225. PubMed ID: 33177102
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in Disease-Modifying Antirheumatic Drug Treatment for Patients With Rheumatoid Arthritis in the US During the COVID-19 Pandemic: A Three-Month Observational Study.
    Michaud K; Pedro S; Wipfler K; Agarwal E; Katz P
    Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1322-1331. PubMed ID: 33787086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of golimumab combined with methotrexate on radiographic progression in rheumatoid arthritis: comment on the article by Emery et al.
    Graudal N; Jürgens G
    Arthritis Rheum; 2012 Apr; 64(4):1297-8; author reply 1298-9. PubMed ID: 22231914
    [No Abstract]   [Full Text] [Related]  

  • 32. How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers.
    Chatzidionysiou K; Delcoigne B; Frisell T; Hetland ML; Glintborg B; Dreyer L; Cordtz R; Zobbe K; Nordström D; Trokovic N; Aaltonen K; Provan SA; Grondal G; Gudbjornsson B; Askling J
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32900882
    [No Abstract]   [Full Text] [Related]  

  • 33. On publication policy, combination therapy, and the European League Against Rheumatism recommendations for the management of rheumatoid arthritis: comment on the article by Graudal et al.
    Landewé R; Gorter S; Gaujoux-Viala C; Gossec L; Smolen JS
    Arthritis Rheum; 2011 Oct; 63(10):3182-4; discussion 3184-6. PubMed ID: 21702017
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel approaches to discovery of biomarkers in rheumatoid arthritis: comment on the article by Oswald et al.
    Hudson M; Baron M; Colmegna I; Bernatsky S; Klein Oros K; Pastinen T; Greenwood C
    Arthritis Rheumatol; 2015 May; 67(8):2276-7. PubMed ID: 25988805
    [No Abstract]   [Full Text] [Related]  

  • 35. A perspective from India on the 2010 rheumatoid arthritis classification criteria: comment on the article by Aletaha et al.
    Chopra A
    Arthritis Rheum; 2011 Feb; 63(2):570; author reply 570-1. PubMed ID: 21280013
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of triple therapy versus etanercept plus methotrexate in rheumatoid arthritis: comment on the article by Moreland et al.
    Graudal N; Jürgens G
    Arthritis Rheum; 2013 Feb; 65(2):539. PubMed ID: 23125025
    [No Abstract]   [Full Text] [Related]  

  • 37. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A or methotrexate: comment on the article by Pasero et al.
    Alarcón GS
    Arthritis Rheum; 1997 Apr; 40(4):791-2. PubMed ID: 9125269
    [No Abstract]   [Full Text] [Related]  

  • 38. Classifying Remission in Rheumatoid Arthritis Treat-to-Target Studies: Comment on the Article by Norvang et al.
    Xie W; Zhang Z
    Arthritis Rheumatol; 2020 Aug; 72(8):1406-1407. PubMed ID: 32249529
    [No Abstract]   [Full Text] [Related]  

  • 39. Reply: The effect of triple therapy versus etanercept plus methotrexate in rheumatoid arthritis: comment on the article by Moreland et al.
    Moreland LW
    Arthritis Rheum; 2013 Feb; 65(2):539-40. PubMed ID: 23124989
    [No Abstract]   [Full Text] [Related]  

  • 40. Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade: comment on the article by Buch et al.
    Schiff MH
    Arthritis Rheum; 2005 Jan; 52(1):364-5; author reply 365. PubMed ID: 15641081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.